Division of Hematology and Oncology Archives
Post-transplant diabetes may be reversible: study
Feb. 20, 2020—Post-transplantation diabetes mellitus (PTDM), a common complication of immunosuppressive drugs that are given to prevent transplant rejection, may be reversible and at least partially preventable, researchers at VUMC report.
Park named interim Hematology and Oncology director
Jan. 9, 2020—Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology.
Rathmell receives 2019 Eugene P. Schonfeld Award
Nov. 6, 2019—The Kidney Cancer Association is recognizing the research accomplishments and leadership achievements of W. Kimryn Rathmell, MD, PhD, with its top honor, the Eugene P. Schonfeld Award.
VICC’s Rathmell honored with Louisa Nelson Award
Oct. 3, 2019—Kimryn Rathmell, MD, PhD, director of the Division of Hematology and Oncology, received an award that honors women who embody the achievement, vision and inspiration of the founder of a local distillery.
Study identifies critical regulator of tumor-specific T cell differentiation
Jun. 18, 2019—A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work
Study reframes approach to targeted therapy resistance
Apr. 11, 2019—When a tumor mutates and develops resistance to a targeted therapy, researchers often focus on the acquisition of new mutations within the drug target as they seek an alternative treatment, but a team of Vanderbilt scientists has shown this may not be sufficient.
Bladder cancer research fund honors mentor’s lasting influence
Mar. 28, 2019—The Terry Burke Fund for Bladder Cancer Research at Vanderbilt-Ingram Cancer Center is supporting a range of discovery research aimed at improving outcomes for bladder cancer patients, and it is helping train the next generation of bladder cancer physician-scientists.
Investigators map genomic landscape of very rare cancer
Feb. 28, 2019—A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.
Research explores link between stem cell transplant, diabetes
Jan. 17, 2019—About a decade ago, at the beginning of his career in academic medicine, Brian Engelhardt, MD, MSCI, noticed that many of his patients receiving a stem cell transplant for their blood cancer ended up with diabetes.
Philip’s liver cancer research receives V Foundation support
Dec. 13, 2018—Mary Philip, MD, PhD, has been named a 2019 V Scholar and will receive $200,000 from the V Foundation for Cancer Research.
Teamwork key to treating patient’s rare blood cancer
Nov. 29, 2018—Former sports journalist Joe Lofaro has little memory of Oct. 23, 2015, when his son Daniel loaded him into a car at his Martin, Tennessee, home and said, ‘Come on, Dad, we’re going for a ride.”
Clinical fellows program bolstered by new NCI grant
Nov. 8, 2018—A new grant from the National Cancer Institute (NCI) will fund an intensively mentored training experience for clinical fellows at Vanderbilt University Medical Center for the next five years.
